Berkan Armağan

1.6k total citations
116 papers, 602 citations indexed

About

Berkan Armağan is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Berkan Armağan has authored 116 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Rheumatology, 29 papers in Pulmonary and Respiratory Medicine and 28 papers in Molecular Biology. Recurrent topics in Berkan Armağan's work include Systemic Lupus Erythematosus Research (22 papers), Inflammasome and immune disorders (21 papers) and Vasculitis and related conditions (17 papers). Berkan Armağan is often cited by papers focused on Systemic Lupus Erythematosus Research (22 papers), Inflammasome and immune disorders (21 papers) and Vasculitis and related conditions (17 papers). Berkan Armağan collaborates with scholars based in Türkiye, United States and United Kingdom. Berkan Armağan's co-authors include Abdülsamet Erden, Umut Kalyoncu, Ömer Karadağ, Levent Kılıç, Alper Sarı, İhsan Ertenli, Sedat Kiraz, Ali Akdoğan, Şule Apraş Bilgen and Serdar Can Güven and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and British Journal Of Nutrition.

In The Last Decade

Berkan Armağan

94 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Berkan Armağan Türkiye 13 208 208 172 165 106 116 602
Şule Apraş Bilgen Türkiye 13 157 0.8× 239 1.1× 159 0.9× 135 0.8× 94 0.9× 72 519
Ayşe Çefle Türkiye 17 279 1.3× 492 2.4× 267 1.6× 198 1.2× 122 1.2× 94 1.0k
Timuçin Kaşifoğlu Türkiye 16 426 2.0× 317 1.5× 290 1.7× 148 0.9× 128 1.2× 80 873
Mikako Warren United States 12 112 0.5× 83 0.4× 201 1.2× 136 0.8× 171 1.6× 47 668
Bernd Raffeiner Italy 12 117 0.6× 324 1.6× 197 1.1× 70 0.4× 58 0.5× 31 649
Murat Turgay Türkiye 13 102 0.5× 237 1.1× 120 0.7× 141 0.9× 61 0.6× 74 581
Diego F. Hernández‐Ramírez Mexico 11 116 0.6× 240 1.2× 267 1.6× 80 0.5× 139 1.3× 30 650
Petra Król Sweden 10 259 1.2× 104 0.5× 149 0.9× 112 0.7× 84 0.8× 15 490
I. Ben Ghorbel Tunisia 15 109 0.5× 324 1.6× 92 0.5× 250 1.5× 88 0.8× 109 830
Selcan Demir Türkiye 18 375 1.8× 267 1.3× 305 1.8× 169 1.0× 222 2.1× 71 925

Countries citing papers authored by Berkan Armağan

Since Specialization
Citations

This map shows the geographic impact of Berkan Armağan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berkan Armağan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berkan Armağan more than expected).

Fields of papers citing papers by Berkan Armağan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berkan Armağan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berkan Armağan. The network helps show where Berkan Armağan may publish in the future.

Co-authorship network of co-authors of Berkan Armağan

This figure shows the co-authorship network connecting the top 25 collaborators of Berkan Armağan. A scholar is included among the top collaborators of Berkan Armağan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Berkan Armağan. Berkan Armağan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Babaoğlu, Hakan, Serdar Can Güven, İsmail Doğan, et al.. (2025). Comorbidity Profile of Familial Mediterranean Fever Patients Varies by Treatments. AYBU AVESIS. 7(1). 53–60.
2.
Babaoğlu, Hakan, et al.. (2025). The role of high large unstained cell percentages in ongoing inflammation in the intercritical gout. Joint Diseases and Related Surgery. 36(2). 366–372.
3.
Armağan, Berkan, et al.. (2025). The Role of Central Sensitization in Autoimmune Connective Tissue Diseases: A Comparative Cross‐Sectional Study. International Journal of Rheumatic Diseases. 28(1). e70069–e70069. 1 indexed citations
4.
Özkaya, Özay, Aylın Okçu Heper, Mehmet Akif Öztürk, et al.. (2024). The impact of histopathological criteria for definite vasculitis in giant cell arteritis: retrospective analysis of temporal artery biopsies. Rheumatology International. 44(11). 2547–2554.
5.
Armağan, Berkan, Serdar Can Güven, İsmail Doğan, et al.. (2024). Obesity might not alter tofacitinib drug survival in rheumatoid arthritis patients. Wiener klinische Wochenschrift. 137(1-2). 49–55. 1 indexed citations
6.
Erden, Abdülsamet, et al.. (2023). Semaphorin 3A levels in vascular and nonvascular phenotypes in systemic sclerosis. Laboratory Medicine. 54(6). 646–651. 2 indexed citations
7.
Armağan, Berkan, Serdar Can Güven, Abdülsamet Erden, et al.. (2023). COVID‐19 disease frequency, risk factors, and re‐infection rates in patients with autoimmune rheumatic disease receiving rituximab. International Journal of Rheumatic Diseases. 26(5). 930–937. 1 indexed citations
8.
Erden, Abdülsamet, Serdar Can Güven, Berkan Armağan, et al.. (2023). Ustekinumab in Enteropathic Arthritis. Immunotherapy. 15(8). 583–592. 4 indexed citations
9.
Güven, Serdar Can, Berkan Armağan, Kevser Gök, et al.. (2022). A single‐center COVID‐19 vaccine experience with CoronaVac and BNT162b2 in familial Mediterranean fever patients. International Journal of Rheumatic Diseases. 25(7). 787–794. 4 indexed citations
10.
11.
Armağan, Berkan, Serdar Can Güven, Abdülsamet Erden, et al.. (2022). Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center. Immunopharmacology and Immunotoxicology. 45(4). 395–401. 2 indexed citations
12.
Erden, Abdülsamet, Antonis Fanouriakis, Serdar Can Güven, et al.. (2022). Performance of the systemic lupus erythematosus risk probability index in a cohort of undifferentiated connective tissue disease. Lara D. Veeken. 61(9). 3606–3613. 8 indexed citations
13.
Erden, Abdülsamet, et al.. (2022). Evaluation of patients with antiphospholipid syndrome subsequently COVID‐19 vaccinations: A retrospective cohort study. International Journal of Rheumatic Diseases. 26(2). 292–297. 6 indexed citations
14.
Güven, Serdar Can, et al.. (2022). Restless leg syndrome and sleep quality in granulomatosis with polyangiitis. 14(3). 124–130. 1 indexed citations
15.
Erden, Abdülsamet, et al.. (2022). Clinical Course of Idiopathic Inflammatory Myopathies in the COVID-19 Pandemic: A single-center Experience. Future Virology. 17(8). 545–556. 2 indexed citations
16.
Bilge, Nazife Şule Yaşar, Nuh Ataş, Berkan Armağan, et al.. (2021). Appendectomy history is associated with severe disease and colchicine resistance in adult familial Mediterranean fever patients. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(4). 1706–1711. 1 indexed citations
17.
Şimşek, Cem, et al.. (2021). Fecal S100A12 in Takayasu arteritis predicts disease activity and intestinal involvement. Rheumatology International. 42(4). 737–742. 2 indexed citations
18.
Kılıç, Levent, Ömer Karadağ, Berkan Armağan, et al.. (2019). Anti-interleukin-6 (tocilizumab) therapy in Takayasu's arteritis: real-life experience. TURKISH JOURNAL OF MEDICAL SCIENCES. 50(1). 31–36. 6 indexed citations
19.
Ataş, Nuh, Berkan Armağan, Hasan Satış, et al.. (2019). Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study. Rheumatology International. 40(1). 41–48. 41 indexed citations
20.
Akdoğan, Ali, Abdülsamet Erden, Levent Kılıç, et al.. (2019). Capillaroscopic findings in Turkish Takayasu arteritis patients. TURKISH JOURNAL OF MEDICAL SCIENCES. 49(5). 1303–1307. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Şule Apraş Bilgen Breakdown of academic impact, for papers by Ayşe Çefle Breakdown of academic impact, for papers by Timuçin Kaşifoğlu Breakdown of academic impact, for papers by Mikako Warren Breakdown of academic impact, for papers by Bernd Raffeiner Breakdown of academic impact, for papers by Murat Turgay Breakdown of academic impact, for papers by Diego F. Hernández‐Ramírez Breakdown of academic impact, for papers by Petra Król Breakdown of academic impact, for papers by I. Ben Ghorbel Breakdown of academic impact, for papers by Selcan Demir
Rankless by CCL
2026